-
Bristol Myers to build first cell therapy factory in Europe — Teva CEO Schultz sees a 35% raise despite company's legal woes — Why Biogen Q1 earnings weren't good enoughSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Latest News - ADU won't be approved
Discussion in 'BiogenIdec' started by anonymous, Oct 19, 2020 at 9:26 AM.
Tags:
Add Tags
Page 8 of 8
Page 8 of 8